Related Experiment Videos
Apoptosis: mechanisms and relation to AIDS
G Famularo1, C De Simone, S Marcellini
1Department of Experimental Medicine, University of L'Aquila, Italy.
Medical Hypotheses
|May 1, 1997
Summary
Human immunodeficiency virus (HIV) infection can trigger programmed cell death (apoptosis) in lymphocytes, contributing to acquired immunodeficiency syndrome (AIDS). Antioxidants may help by reducing this cell death in HIV-infected individuals.
Area of Science:
- Immunology
- Virology
- Cell Biology
Background:
- Human immunodeficiency virus (HIV) infection leads to acquired immunodeficiency syndrome (AIDS) through immune system decline.
- HIV infection is increasingly linked to programmed cell death (apoptosis) of lymphocytes, exacerbating immune deficiency.
Purpose of the Study:
- To review host- and HIV-related factors that induce lymphocyte apoptosis during HIV infection.
- To explore the role of oxidative stress, tumor necrosis factor (TNF), and ceramide in HIV-induced apoptosis.
- To discuss the therapeutic implications of targeting apoptosis in AIDS treatment.
Main Methods:
- Literature review of studies investigating HIV pathogenesis and lymphocyte apoptosis.
- Analysis of factors including cellular redox balance, TNF signaling, and sphingomyelin pathway activation.
- Evaluation of the antiapoptotic effects of antioxidant compounds.
Main Results:
- HIV infection can induce lymphocyte apoptosis through various host and viral factors.
- Oxidant/antioxidant imbalance, TNF, and ceramide are key mediators in HIV-associated apoptosis.
- Antioxidant compounds demonstrate significant antiapoptotic activity in available data.
Conclusions:
- Understanding apoptosis mechanisms is crucial for developing novel AIDS treatment strategies.
- Antioxidants show promise in mitigating HIV-induced lymphocyte loss.
- Combination therapy with antiretroviral drugs and antioxidants may benefit HIV-infected patients.